(DRUG) Bright Minds - Performance 2116% in 12m
DRUG performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
-3.46%
#36 in Peer-Group
Rel. Strength
99.97%
#3 in Stock-Universe
Total Return 12m
2115.98%
#2 in Peer-Group
Total Return 5y
-13.81%
#38 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | - |
| P/E Forward | - |
| High / Low | USD |
|---|---|
| 52 Week High | 55.77 USD |
| 52 Week Low | 0.96 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 3.80 |
| Buy/Sell Signal +-5 | -2.09 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: DRUG (2116%) vs XBI (-10.8%)
5y Drawdown (Underwater) Chart
Top Performer in Biotechnology
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| GILD NASDAQ Gilead Sciences |
0.31% | 66.4% | 81.3% | 22.7 | 13.6 | 0.23 | 28.3% | -3.71% |
| UTHR NASDAQ United Therapeutics |
-11.3% | -10.9% | 137% | 11.3 | 10.5 | 1.43 | 74.6% | 16.1% |
| AMGN NASDAQ Amgen |
-2.26% | -8.02% | 39.9% | 25.4 | 13.4 | 0.93 | 0.60% | 41% |
| BIM PA Biomerieux |
2.47% | 33.7% | 4.38% | 33.1 | 25.8 | 1.55 | -38.5% | -25.1% |
| KMDA NASDAQ Kamada |
12.2% | 64.2% | 3.4% | 25.5 | 22.8 | 0.91 | 48.1% | 3.93% |
| NBIX NASDAQ Neurocrine Biosciences |
1.42% | -10.5% | -0.06% | 43 | 24.8 | 0.27 | 18.7% | -34.3% |
| PTCT NASDAQ PTC Therapeutics |
1.94% | 59.9% | -1.58% | 7.71 | 6.26 | 0.81 | - | 68% |
| ERF PA Eurofins Scientific SE |
6.88% | 35.5% | 16% | 28.9 | 15.1 | 0.63 | -62.1% | -19.3% |
Performance Comparison: DRUG vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for DRUG
| Total Return (including Dividends) | DRUG | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -14.92% | 3.18% | 4.52% |
| 3 Months | -35.49% | 2.36% | 10.25% |
| 12 Months | 2115.98% | -10.75% | 14.16% |
| 5 Years | -13.81% | -24.51% | 116.91% |
| Trend Score (consistency of price movement) | DRUG | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -25.3% | 30.9% | 79.1% |
| 3 Months | -76.2% | 63.2% | 91.7% |
| 12 Months | 37% | -83.8% | 44% |
| 5 Years | -19.5% | -52.9% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th15.50 | -17.54% | -18.60% |
| 3 Month | %th7.50 | -36.98% | -41.49% |
| 12 Month | %th100.00 | 2382.93% | 1841.06% |
| 5 Years | %th85.50 | 52.48% | -48.17% |
FAQs
Does Bright Minds (DRUG) outperform the market?
Yes,
over the last 12 months DRUG made 2115.98%, while its related Sector, the SPDR S&P Biotech (XBI) made -10.75%.
Over the last 3 months DRUG made -35.49%, while XBI made 2.36%.
Performance Comparison DRUG vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
DRUG vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -16.6% | -19.4% | -42% | 2102% |
| US NASDAQ 100 | QQQ | -17.2% | -20.5% | -43.5% | 2102% |
| German DAX 40 | DAX | -17.4% | -15.3% | -57.2% | 2085% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -15.9% | -17.4% | -38% | 2099% |
| Hongkong Hang Seng | HSI | -16.9% | -21.8% | -59.2% | 2080% |
| India NIFTY 50 | INDA | -17% | -17.3% | -43% | 2116% |
| Brasil Bovespa | EWZ | -15.8% | -18.4% | -63.7% | 2105% |
DRUG vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -17.8% | -21.8% | -48.3% | 2088% |
| Consumer Discretionary | XLY | -16.1% | -16.8% | -34% | 2095% |
| Consumer Staples | XLP | -13.1% | -13.7% | -40.9% | 2107% |
| Energy | XLE | -13.3% | -19.5% | -39.4% | 2119% |
| Financial | XLF | -16.3% | -17.4% | -45.2% | 2088% |
| Health Care | XLV | -15.4% | -16.6% | -35.3% | 2122% |
| Industrial | XLI | -16.1% | -18.1% | -48.8% | 2092% |
| Materials | XLB | -15.2% | -17.3% | -42.8% | 2113% |
| Real Estate | XLRE | -11.9% | -14.5% | -40.4% | 2104% |
| Technology | XLK | -17.4% | -23.4% | -44.2% | 2105% |
| Utilities | XLU | -14.2% | -15.9% | -45.7% | 2092% |
| Aerospace & Defense | XAR | -18.4% | -24.5% | -63.1% | 2064% |
| Biotech | XBI | -15% | -18.1% | -29.2% | 2127% |
| Homebuilder | XHB | -15.2% | -18.8% | -31.5% | 2115% |
| Retail | XRT | -14.3% | -17.1% | -34.6% | 2109% |
DRUG vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | -10% | -24.0% | -34.8% | 2126% |
| Natural Gas | UNG | -12.3% | -18.4% | -28.6% | 2116% |
| Gold | GLD | -10.9% | -13.5% | -62.1% | 2076% |
| Silver | SLV | -13.1% | -22.6% | -60.3% | 2094% |
| Copper | CPER | -17.4% | -23.5% | -60.4% | 2101% |
DRUG vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | -14.8% | -16.7% | -38.2% | 2115% |
| iShares High Yield Corp. Bond | HYG | -14.6% | -16.5% | -41.5% | 2106% |